Senior insider sale
VP, Corp Controller and CAO at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$2.82M
77.43K shares
What this filing means
CALVIN SANDRA plans to sell 77.43K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $2.82M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2025ACC: 0001950047-25-010713
Officer· VP, Corp Controller and CAO
Since Sep 2021
77.43K
Shares to sell
$2.82M
Approx. market value
7.40K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months5
Restricted Stock
Not Applicable
1/31/2024
2.67KRestricted Stock
Not Applicable
1/21/2024
1.28KRestricted Stock
Not Applicable
1/31/2023
1.11KRestricted Stock
Not Applicable
1/21/2023
1.09KRestricted Stock
Not Applicable
1/21/2022
1.25KTotal acquired7.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2024 | Restricted Stock Not Applicable | 2.67K | — |
1/21/2024 | Restricted Stock Not Applicable | 1.28K | — |
1/31/2023 | Restricted Stock Not Applicable | 1.11K | — |
1/21/2023 | Restricted Stock Not Applicable | 1.09K | — |
1/21/2022 | Restricted Stock Not Applicable | 1.25K | — |
| Total | 7.40K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
2.91K
Market value
$104.8K
12/15/2025
—Completed
Units to sell
67.11K
Market value
$2.42M
11/4/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
7.40K
Market value
$296.1K
12/24/2025
Total
Units
77.43K
Value
$2.82M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/15/2025 | 2.91K | $104.8K | — | Completed |
11/4/2025 | 67.11K | $2.42M | — | Completed |
| Planned — Approximate Date | ||||
12/24/2025 | 7.40K | $296.1K | NASDAQ | Planned |
| Total | 77.43K | $2.82M | ||